RT @IDstewardship: ⭐️🆕⭐️ IDSA 💨 HAP/VAP Guideline!! Inhaled abx recommended with resistant GNB https://t.co/9jJdjb3XkG vIa @IDSAInfo https:…
RT @BBookstaver_USC: @IDSAInfo and ATS release 2016 update to HAP/VAP guidelines. https://t.co/4uOreGYccG #IDPRN
RT @DrMagicianEARL: 成人の院内肺炎および人工呼吸器関連肺炎の管理:IDSA/ATS診療ガイドライン2016(Clin Infect Dis 2016, July14) https://t.co/F64r212qhw 新しいの出ました。ちらっとだけ推奨見たけ…
RT @khalideljaaly: 📢The IDSA/ATS guidelines for HAP/VAP got published https://t.co/7Qksn4AwW8
RT @IDstewardship: ⭐️🆕⭐️ IDSA 💨 HAP/VAP Guideline!! Inhaled abx recommended with resistant GNB https://t.co/9jJdjb3XkG vIa @IDSAInfo https:…
RT @SIDPharm: New IDSA/ATS VAP guidelines https://t.co/bswYek9UiT
RT @DrMagicianEARL: 成人の院内肺炎および人工呼吸器関連肺炎の管理:IDSA/ATS診療ガイドライン2016(Clin Infect Dis 2016, July14) https://t.co/F64r212qhw 新しいの出ました。ちらっとだけ推奨見たけ…
RT @SIDPharm: New IDSA/ATS VAP guidelines https://t.co/bswYek9UiT
RT @IDstewardship: ⭐️🆕⭐️ IDSA 💨 HAP/VAP Guideline!! Inhaled abx recommended with resistant GNB https://t.co/9jJdjb3XkG vIa @IDSAInfo https:…
RT @IDstewardship: ⭐️🆕⭐️ IDSA 💨 HAP/VAP Guideline!! Inhaled abx recommended with resistant GNB https://t.co/9jJdjb3XkG vIa @IDSAInfo https:…
RT @IDstewardship: ⭐️🆕⭐️ IDSA 💨 HAP/VAP Guideline!! Inhaled abx recommended with resistant GNB https://t.co/9jJdjb3XkG vIa @IDSAInfo https:…
RT @accpinfdprn: New @IDSAInfo HAP/VAP Guidelines released: https://t.co/nb79iBkNqi
RT @IDPharmProf: New HAP/VAP guidelines in CID adv access today. Long awaited. https://t.co/gngM4e1e47
RT @accpinfdprn: New @IDSAInfo HAP/VAP Guidelines released: https://t.co/nb79iBkNqi
RT @IDPharmProf: New HAP/VAP guidelines in CID adv access today. Long awaited. https://t.co/gngM4e1e47
New IDSA HAP/VAP guidelines https://t.co/qd941diHuD
RT @DrMagicianEARL: 成人の院内肺炎および人工呼吸器関連肺炎の管理:IDSA/ATS診療ガイドライン2016(Clin Infect Dis 2016, July14) https://t.co/F64r212qhw 新しいの出ました。ちらっとだけ推奨見たけ…
RT @SIDPharm: New IDSA/ATS VAP guidelines https://t.co/bswYek9UiT
RT @accpinfdprn: New @IDSAInfo HAP/VAP Guidelines released: https://t.co/nb79iBkNqi
RT @SIDPharm: New IDSA/ATS VAP guidelines https://t.co/bswYek9UiT
RT @DrMagicianEARL: 成人の院内肺炎および人工呼吸器関連肺炎の管理:IDSA/ATS診療ガイドライン2016(Clin Infect Dis 2016, July14) https://t.co/F64r212qhw 新しいの出ました。ちらっとだけ推奨見たけ…
RT @IDstewardship: ⭐️🆕⭐️ IDSA 💨 HAP/VAP Guideline!! Inhaled abx recommended with resistant GNB https://t.co/9jJdjb3XkG vIa @IDSAInfo https:…
RT @DrMagicianEARL: 成人の院内肺炎および人工呼吸器関連肺炎の管理:IDSA/ATS診療ガイドライン2016(Clin Infect Dis 2016, July14) https://t.co/F64r212qhw 新しいの出ました。ちらっとだけ推奨見たけ…
RT @SIDPharm: New IDSA/ATS VAP guidelines https://t.co/bswYek9UiT
RT @SIDPharm: New IDSA/ATS VAP guidelines https://t.co/bswYek9UiT
RT @IDPharmProf: New HAP/VAP guidelines in CID adv access today. Long awaited. https://t.co/gngM4e1e47
RT @SIDPharm: New IDSA/ATS VAP guidelines https://t.co/bswYek9UiT
RT @IDstewardship: ⭐️🆕⭐️ IDSA 💨 HAP/VAP Guideline!! Inhaled abx recommended with resistant GNB https://t.co/9jJdjb3XkG vIa @IDSAInfo https:…
⭐️🆕⭐️ IDSA 💨 HAP/VAP Guideline!! Inhaled abx recommended with resistant GNB https://t.co/9jJdjb3XkG vIa @IDSAInfo https://t.co/vaXed7cXN7
RT @IDPharmProf: New HAP/VAP guidelines in CID adv access today. Long awaited. https://t.co/gngM4e1e47
RT @accpinfdprn: New @IDSAInfo HAP/VAP Guidelines released: https://t.co/nb79iBkNqi
New pneumonia guidelines have released. https://t.co/C0tJ4X20Mv
RT @khalideljaaly: 📢The IDSA/ATS guidelines for HAP/VAP got published https://t.co/7Qksn4AwW8
RT @accpinfdprn: New @IDSAInfo HAP/VAP Guidelines released: https://t.co/nb79iBkNqi
RT @accpinfdprn: New @IDSAInfo HAP/VAP Guidelines released: https://t.co/nb79iBkNqi
New @IDSAInfo HAP/VAP Guidelines released: https://t.co/nb79iBkNqi
RT @cynth_ID: VAP 2/2 non-lactose fermenting GNR should receive 7 d abx. Benefits of short course outweighs harm. https://t.co/pnbjr8K8Cv
RT @cynth_ID: VAP 2/2 non-lactose fermenting GNR should receive 7 d abx. Benefits of short course outweighs harm. https://t.co/pnbjr8K8Cv
VAP 2/2 non-lactose fermenting GNR should receive 7 d abx. Benefits of short course outweighs harm. https://t.co/pnbjr8K8Cv
IDSA VAP/HAPガイドラインでました。サラッと流し読みしましたが、興味深かったです。 https://t.co/yzng0hR9YV
RT @SIDPharm: New IDSA/ATS VAP guidelines https://t.co/bswYek9UiT
RT @SIDPharm: New IDSA/ATS VAP guidelines https://t.co/bswYek9UiT
RT @khalideljaaly: 📢The IDSA/ATS guidelines for HAP/VAP got published https://t.co/7Qksn4AwW8
@IDSAInfo and ATS release 2016 update to HAP/VAP guidelines. https://t.co/4uOreGYccG #IDPRN
Long overdue guidelines for HAP and VAP from IDSA and ATS. Glad to see they removed HCAP from these guidelines. https://t.co/npXV0RRKgO
RT @SIDPharm: New IDSA/ATS VAP guidelines https://t.co/bswYek9UiT
RT @IDPharmProf: New HAP/VAP guidelines in CID adv access today. Long awaited. https://t.co/gngM4e1e47
RT @IDPharmProf: New HAP/VAP guidelines in CID adv access today. Long awaited. https://t.co/gngM4e1e47
RT @rdangelo1077: HCAP removed as an indication for broad spec abx's! https://t.co/LofKNJFY8T
RT @IDPharmProf: New HAP/VAP guidelines in CID adv access today. Long awaited. https://t.co/gngM4e1e47
RT @IDPharmProf: New HAP/VAP guidelines in CID adv access today. Long awaited. https://t.co/gngM4e1e47
New #HAP/#VAP guidelines in CID today after long awaited release. Apparently no new lit has come out since 2005. https://t.co/4O9No1VSiB
RT @khalideljaaly: 📢The IDSA/ATS guidelines for HAP/VAP got published https://t.co/7Qksn4AwW8
RT @SIDPharm: New IDSA/ATS VAP guidelines https://t.co/bswYek9UiT
RT @SIDPharm: New IDSA/ATS VAP guidelines https://t.co/bswYek9UiT
RT @khalideljaaly: 📢The IDSA/ATS guidelines for HAP/VAP got published https://t.co/7Qksn4AwW8
RT @khalideljaaly: 📢The IDSA/ATS guidelines for HAP/VAP got published https://t.co/7Qksn4AwW8
📢The IDSA/ATS guidelines for HAP/VAP got published https://t.co/7Qksn4AwW8
HCAP removed as an indication for broad spec abx's! https://t.co/LofKNJFY8T
New IDSA/ATS VAP guidelines https://t.co/bswYek9UiT